Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients

Clin Transplant. 2022 Mar;36(3):e14601. doi: 10.1111/ctr.14601. Epub 2022 Jan 28.

Authors

Christopher Radcliffe¹, Marwan M Azar², Elizabeth Cohen³, Mollie Tucker², Nathan D Grubaugh⁴, Maricar Malinis²

Affiliations

¹ Yale University School of Medicine, New Haven, Connecticut, USA.
² Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
³ Yale New Haven Transplant Center, New Haven, Connecticut, USA.
⁴ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.

PMID: 35064939
DOI: 10.1111/ctr.14601

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19* / epidemiology
COVID-19* / prevention & control
Humans
Organ Transplantation*
SARS-CoV-2
Transplant Recipients
Treatment Outcome

Substances

COVID-19 Vaccines